Cargando…

Applications of Extracellular Vesicles in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the deadliest subtype of breast cancer, with limited treatment options. This review summarizes the most recent applications of extracellular vesicles (EVs) in TNBC as diagnostic/prognostic biomarkers, nanoscale drug delivery systems (NDDS) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	St-Denis-Bissonnette, Frederic, Khoury, Rachil, Mediratta, Karan, El-Sahli, Sara, Wang, Lisheng, Lavoie, Jessie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773485/ https://www.ncbi.nlm.nih.gov/pubmed/35053616 http://dx.doi.org/10.3390/cancers14020451

Ejemplares similares

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer
por: Kirkby, Melanie, et al.
Publicado: (2023)

Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2019)

Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell
por: Gobin, Jonathan, et al.
Publicado: (2021)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2020)

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023)

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023)

Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
por: Tkach, Mercedes, et al.
Publicado: (2022)

The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
por: Zhou, Yueyuan, et al.
Publicado: (2022)

Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
por: El-Sahli, Sara, et al.
Publicado: (2020)

Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer
por: Nishida-Aoki, Nao, et al.
Publicado: (2020)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
por: Pederson, Petra J., et al.
Publicado: (2021)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer
por: Duan, Suzann, et al.
Publicado: (2021)

Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
por: Yi, Yong Weon
Publicado: (2023)

Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018)

Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
por: Kavanagh, E L, et al.
Publicado: (2017)

The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
por: Howard, Jane, et al.
Publicado: (2021)

Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
por: Vannini, Ivan, et al.
Publicado: (2022)

Small Extracellular Vesicles from Hypoxic Triple-Negative Breast Cancer Cells Induce Oxygen-Dependent Cell Invasion
por: Pachane, Bianca Cruz, et al.
Publicado: (2022)

Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple‐negative breast cancer patients for potential biomarker development
por: Vikramdeo, Kunwar Somesh, et al.
Publicado: (2023)

Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
por: Manouchehri, Jasmine M., et al.
Publicado: (2022)

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
por: Sulaiman, Andrew, et al.
Publicado: (2018)

Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors
por: Sulaiman, Andrew, et al.
Publicado: (2017)

Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer
por: Mohammed, Mohammed Elimam Ahamed, et al.
Publicado: (2019)

Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix
por: Zolota, Vasiliki, et al.
Publicado: (2021)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
por: Lopatina, Tatiana, et al.
Publicado: (2020)

The role and application of small extracellular vesicles in breast cancer
por: Yi, Xiaomei, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
por: Lopatina, Tatiana, et al.
Publicado: (2023)

Current approaches in treatment of triple-negative breast cancer
por: Wahba, Hanan Ahmed, et al.
Publicado: (2015)

The application of exosomes in the treatment of triple-negative breast cancer
por: Weaver, John W., et al.
Publicado: (2022)

A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
por: El-Sahli, Sara, et al.
Publicado: (2021)

The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
por: Ulhaka, Karan, et al.
Publicado: (2021)

Wnt Signaling in Cancer Metabolism and Immunity
por: El-Sahli, Sara, et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer
por: Desai, Priyanka P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uccqso177ovsck3qs9jj9hmhth